Compass Therapeutics, Inc. (CMPX)

NASDAQ: CMPX · Real-Time Price · USD

2.060

-0.040 (-1.90%)

At close: Jun 23, 2026, 4:00 PM EDT

2.070

+0.010 (0.48%)

After-hours: Jun 23, 2026, 5:23 PM EDT

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	55.17	30.64	43.48	24.23	34.95	144.51
Short-Term Investments	139.52	178.26	83.24	128.23	151.66	-
Cash & Short-Term Investments	194.69	208.91	126.72	152.46	186.61	144.51
Cash Growth	72.85%	64.85%	-16.88%	-18.30%	29.13%	206.98%
Other Current Assets	1	0.91	6.03	1.42	8.18	2.59
Total Current Assets	195.69	209.82	132.75	153.88	194.79	147.11
Net Property, Plant & Equipment	8.92	9.45	7.3	2.67	4.53	6.33
Other Long-Term Assets	0.57	0.32	0.35	0.32	0.32	0.32
Total Assets	205.17	219.59	140.4	156.88	199.65	153.76
Accounts Payable	0.91	1.59	2.25	4.09	3.38	0.87
Accrued Expenses	8	11.38	6.29	2.51	11.69	8.78
Current Portion of Leases	1.37	1	0.34	1.2	1.1	0.99
Total Current Liabilities	10.28	13.97	8.87	7.8	16.17	10.63
Long-Term Leases	8.42	8.83	6.3	0.54	1.84	3.05
Total Long-Term Liabilities	8.42	8.83	6.3	0.54	1.84	3.05
Total Liabilities	18.7	22.8	15.17	8.34	18.01	13.68
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	636.1	627.67	489.69	463.8	454.74	373.66
Accumulated Other Comprehensive Income	-0.16	0.28	0.21	0.04	-0.3	-
Retained Earnings	-449.49	-431.17	-364.68	-315.31	-272.81	-233.59
Shareholders' Equity	186.47	196.79	125.23	148.54	181.64	140.08
Total Liabilities & Equity	205.17	219.59	140.4	156.88	199.65	153.76
Total Debt	9.79	9.83	6.63	1.73	2.94	4.04
Net Cash (Debt)	184.9	199.08	120.09	150.73	183.67	140.48
Net Cash Growth	-7.12%	65.78%	-20.33%	-17.94%	30.75%	272.20%
Net Cash Per Share	1.09	1.26	0.87	1.19	1.75	2.23
Book Value	186.47	196.79	125.23	148.54	181.64	140.08
Book Value Per Share	1.10	1.25	0.91	1.17	1.73	2.23
Tangible Book Value	186.47	196.79	125.23	148.54	181.64	140.08
Tangible Book Value Per Share	1.10	1.25	0.91	1.17	1.73	2.23

SEC Filings: 10-K · 10-Q